EU says Russia making false claims about other vaccines to help sell its own
Western vaccine developers are openly mocked on Russian state-controlled media, leading to claims that other vaccines will turn people into monkeys
Brussels — The EU’s top diplomat said on Monday that Russian public media has spread false information on European and American Covid-19 vaccines in countries where it wants to sell its own shot against the coronavirus.
“Western vaccine developers are openly mocked on multi-lingual Russian state-controlled media, which has, in some cases, led to absurd claims that vaccines will turn people into monkeys,” Josep Borrell said in a blog post.
“Such narratives are apparently directed at countries where Russia wants to sell its own vaccine, Sputnik V,” Borrell said, noting that these moves threatened public health amid the Covid-19 pandemic. He gave no specific examples.
Moscow has repeatedly denied these accusations, and alleges that Sputnik V is being targeted by a foreign-backed disinformation campaign.
The Russian Direct Investment Fund (RDIF), which is responsible for marketing the vaccine abroad, did not immediately respond to a request for comment on Borrell’s statement. The health ministry did not immediately respond to a request for comment. Roskomnadzor, the Russian media and communications watchdog, also did not respond immediately.
When drugmaker AstraZeneca, which worked with Oxford University on its vaccine, paused a clinical trial in September due to the then unexplained illness of a volunteer, Kremlin spokesperson Dmitry Peskov told reporters that Sputnik V was more reliable because it was based on an adenovirus found in humans, whereas the British candidate was a “monkey vaccine”.
Trials of the vaccine, which uses a bioengineered version of a harmless common cold virus found in chimpanzees to instruct human cells to make antigens, were resumed in Britain within days after getting the green light from safety watchdogs.
Last week, Russia dispatched its first batch of coronavirus vaccine to Argentina as part of a 10-million-dose deal. It has signed supply deals with a number of other Latin American and Asian countries. The Russian shot costs less than $20 per person for the necessary two doses.
Would you like to comment on this article or view other readers' comments?
Register (it’s quick and free) or sign in now.
Please read our Comment Policy before commenting.